Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roxann M Neumann

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Seminars in Oncology Nursing|May 6, 2014
Biospecimen collection, processing, and analysis: new challenges for oncology nursesRoxann M Neumann, Colleen Garvey, Sharon Kaufman
Human Mutation|August 31, 2006
Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell linesLi Zheng, Fengwei Wang, Chiping Qian, et al.
The Journal of Urology|August 18, 2004
Phyllodes tumor of the prostate: long-term followup study of 23 casesDavid G Bostwick, Deloar Hossain, Junqi Qian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancerDonkena Krishna Vanaja, Karla V Ballman, Bruce W Morlan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Seminars in Oncology Nursing|May 6, 2014
Biospecimen collection, processing, and analysis: new challenges for oncology nursesRoxann M Neumann, Colleen Garvey, Sharon Kaufman
Human Mutation|August 31, 2006
Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell linesLi Zheng, Fengwei Wang, Chiping Qian, et al.
The Journal of Urology|August 18, 2004
Phyllodes tumor of the prostate: long-term followup study of 23 casesDavid G Bostwick, Deloar Hossain, Junqi Qian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancerDonkena Krishna Vanaja, Karla V Ballman, Bruce W Morlan, et al.
Pageof 1